Pilot open-label study of nefazodone in
โ
Alexander Bystritsky; Richard Rosen; Rita Suri; Tanya Vapnik
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 56 KB
๐ 1 views
Ten patients meeting DSM-IV criteria for non-comorbid panic disorder or panic disorder with agoraphobia were treated in a 12-week open-label, flexible dosage trial of nefazodone. Dosages ranged from 50 to 400 mg per day. Clinical assessment utilized several recently developed scales of panic disorde